Why Globe Life (GL) Stock Is Down Today: Q3 2026 Earnings
Delayed snapshot
“Today” refers to the Oct 23, 2026 U.S. market session.
Earnings and the stock move
The decline occurs after Globe Life’s October 21 third-quarter release and October 22 results call. The company reduced its 2026 earnings guidance range from July and described health-claims pressures. Those verified developments provide relevant context, but do not identify the exact cause of the October 23 move. No numerical consensus beat or miss is asserted because matching dated expectations were not independently verified.
Q3 2026 earnings recap
Globe Life traded at $157.00, down 6.78% in the regular session on October 23, 2026 at 12:24 PM Eastern, compared with the previous regular close.
- Third-quarter results released October 21 showed $1.596 billion total revenue, GAAP diluted EPS of $4.62 and non-GAAP net operating EPS of $4.84; the two earnings measures differ.
- The insurer sells basic life and supplemental health protection to middle-income customers through agencies and direct channels. Premiums fund insurance obligations, while invested assets also generate income.
- Premium revenue increased 7% year on year, but health claims were a pressure point. Management identified high-severity Evry claims and delayed Medicare processing as factors affecting quarterly results.
- The 2026 earnings guidance range moved to $15.35–$15.65 from July’s $15.55–$15.95, a $0.25 reduction at the midpoint. Guidance remains an estimate, not a promised result.
- Claims severity, policy lapses, reserve assumptions, investment credit exposure and legal or regulatory costs remain risks; favorable premium growth does not eliminate underwriting uncertainty.
- October 22 completed charts closed at $168.41. The current quote is below the recent $161–164 trading area, so a sustained reclaim would matter more than assuming the old floor will hold.
Aflac’s calendar currently lists its third-quarter release for November 4, a future supplemental-insurance peer checkpoint. Watch claims normalization and earnings quality; the observed decline does not establish one proven cause.
Financials and technicals
Charts through Oct 22, 2026. The session move above may reflect later news.
Technical setup and risks
The October 22 completed session closed at $168.41 after trading as low as $161.52. The October 23 saved quote is below the recent $161–164 area, which includes October7–9 lows and the October22 low. A sustained reclaim would improve stabilization evidence; $168–171 includes repeated October highs and closes. Failure to reclaim leaves downside unresolved. These are observations and conditional scenarios, not guaranteed support or price targets.
AI-assisted research with source and calculation checks. Price snapshots may be delayed. Technical charts use the stated completed session, which can precede the quoted intraday move. Educational information; investing involves risk.